< Return to all Tests

Test Category: Immunology

Investigation Name:Anti-Nuclear Antibodies (ANA)

Alias or Abbreviation:ANA, ANF

Intro:

Indication: Preliminary investigation of connective tissue diseases; autoimmune liver disease. Further information: Anti-nuclear antibodies are relatively non-specific markers of autoimmune disease, particularly connective tissue diseases. They can be induced by some chronic infections. The test is used as an initial screen to assess the need for more specific tests (ENA and anti-DNA antibodies), which are automatically carried out on ANA positive samples The presence of ANA in significant titre (>1/80) is not specific for SLE and can also be seen in 15-50% of patients with other auto-immune diseases e.g., Rheumatoid Arthritis, Sjogren’s syndrome, Scleroderma, Dermatomyositis and in autoimmune liver disease. Weak positive ANA is usually of no specific diagnostic value. NOTE: Positive ANA (>1:80) will reflex a dsDNA and ENA Screen NOTE: Specific ANA patterns will trigger additional reflex tests: • Positive Nucleolar reflex Systemic Sclerosis Antibody Blot • Positive Nuclear dot reflex Autoimmune Liver disease Blot • Positive Nuclear membrane reflex Autoimmune liver Disease Blot NOTE: Positive Cytoplasmic pattern will reflex (depending on pattern): • Myositis Antibodies Blot • ENA Screen • Liver antibody screen (AMA or SMA)

Requestable Seperately?Yes

Minimum Sample Volume:1mL

Expected Turnaround Time:Frequency of testing: Daily Target: 4 days

Test Code:ANA

Sample Type:

Serum Gel Tube (Gold top)

Complex Reference Range:Positive/ Negative Titration is reported when indicated

Collection Conditions / Other Information:1st class post or Transport

Referred to Another Laboratory?No

Storage Requirements:Ambient temperature

NPEX / PDF Reporting Available:Yes

EQA Scheme:Yes

Lead Contact Details:rwh-tr.bcpsimmunologyclinicalqueries@nhs.net

Email Address For Chasing Results:rwh-tr.ImmunologyLab@nhs.net

Methodology:Indirect Immunofluorescence

UKAS Reference Number:Awaiting assessment

Site Sample Tested:Immunology, New Cross Hospital, Wolverhampton

Minimum Request Interval (MRI):180 days (6 months) over 16y only